Adamantane and memantine derivatives as peripheral NMDA receptor antagonists
US10538482B2 · kind B2 · utility
0Cited by
4References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 26, 2016 |
| Grant date | Jan 21, 2020 |
| Priority date | — |
| Expiry date | Jul 26, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to cationic compounds of formula (I) for use as peripheral NMDA receptor antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.